|
61
|
Product specific BE guideline |
Lurasidone hydrochloride tablet_生體相等性試驗指導原則_V2(新增QA)
|
2021-11-22 |
|
62
|
Product specific BE guideline |
Metformin+Glimepiride tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
63
|
Product specific BE guideline |
Montelukast sodium Chewable Tablet, 5 mg, 4 mg_生體相等性試驗指導原則
|
2021-11-22 |
|
64
|
Product specific BE guideline |
Montelukast sodium Oral Granules 4 mg_生體相等性試驗指導原則
|
2021-11-22 |
|
65
|
Product specific BE guideline |
Montelukast sodium Tablets_生體相等性試驗指導原則
|
2021-11-22 |
|
66
|
Product specific BE guideline |
Nebivolol hydrochloride tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
67
|
Product specific BE guideline |
Silodosin Capsule_生體相等性試驗指導原則
|
2021-11-22 |
|
68
|
Product specific BE guideline |
Sitagliptin phosphate_Metformin HCl Tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
69
|
Product specific BE guideline |
Sultamicillin tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
70
|
Product specific BE guideline |
Tamsulosin PR Tablet_生體相等性試驗指導原則
|
2021-11-22 |
